Compare MDXG & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXG | VRTS |
|---|---|---|
| Founded | 2006 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 530.2M | 968.0M |
| IPO Year | 2007 | 1995 |
| Metric | MDXG | VRTS |
|---|---|---|
| Price | $3.79 | $137.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $9.00 | ★ $158.00 |
| AVG Volume (30 Days) | ★ 1.7M | 69.8K |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 6.68% |
| EPS Growth | 14.29 | ★ 18.24 |
| EPS | N/A | ★ 1.05 |
| Revenue | ★ $418,630,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.02 | $1.66 |
| P/E Ratio | ★ N/A | $126.81 |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $3.03 | $121.61 |
| 52 Week High | $7.99 | $214.88 |
| Indicator | MDXG | VRTS |
|---|---|---|
| Relative Strength Index (RSI) | 56.02 | 46.74 |
| Support Level | $3.45 | $135.82 |
| Resistance Level | $7.39 | $147.15 |
| Average True Range (ATR) | 0.13 | 6.27 |
| MACD | 0.05 | -0.94 |
| Stochastic Oscillator | 93.83 | 49.95 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.